NJC
Paper
solution of 3a–3h in 20 mL of pyridine at 0 1C. Diazonium salt 7.49 (d, J = 7.57 Hz, 2H), 7.47 (d, J = 8.82 Hz, 2H), 7.43
of 4-chloro-2-phenoxybenzenamine (4) was added dropwise (t, J = 7.93 Hz, 2H), 7.21 (t, J = 7.37 Hz, 1H), 7.11 (d, J = 7.83
with continuous stirring over 1 h, maintaining the temperature Hz, 2H), 7.04 (d, J = 8.79 Hz, 2H), 7.03 (d, J = 8.45 Hz, 1H), 6.87
below 5 1C. The reaction mixture was allowed to stir for another (d, J = 8.62 Hz, 1H), 3.81 (s, 3H). 13C NMR (126 MHz, CDCl3): d
3 h and then poured into 250 mL of ice-cold water with 159.81, 156.54, 149.98, 143.94, 142.64, 137.36, 132.42, 130.36,
continuous stirring. The resulting violet-coloured viscous solid 130.17, 129.61, 127.47, 124.49, 124.11, 124.04, 122.85, 119.85,
was filtered off, washed with water and recrystallized from 118.15, 114.98, 113.90, 55.38. ESI-MS m/z: 491.0 ((M + H)ꢀ, 70%);
methanol.
490.0 ((M)ꢀ, 70%); 489.0 ((M ꢀ H)ꢀ, 35%). ESI-MS/MS m/z: 395.9
(20%); 284.9 (7%); 250.8 (21%); 202.8 (100%); 174.9 (22%).
Preparation of 5-(4-chloro-2-phenoxyphenyl)-3-(4-methoxyphenyl)-
1-phenylformazans (5a). This compound was obtained from 3a
5-(4-Chloro-2-phenoxyphenyl)-3-(4-methoxyphenyl)-1-(4-bromo-
(1.0 g, 4.40 mmol) and diazonium salt 4 (0.96 g, 4.40 mmol). phenyl)formazan (5d). This compound was obtained from 3d
Formazan 5a (1.65 g, 82%) was obtained as a light violet powder (1.20 g, 3.90 mmol) and diazonium salt 4 (0.86 g, 3.90 mmol) as
with a melting point of 176–177 1C. Rf: 0.63 (n-hexane/ethyl a dark violet solid. Anal. calcd for C26H20BrClN4O2 (%): C, 58.28;
acetate, 5 : 1). Anal. calcd for C26H21ClN4O2 (%): C, 68.34; H, H, 3.76; N, 10.46; found: C, 58.15; H, 3.84; N, 10.43. Yield: 1.81 g
4.63; N, 12.26; found: C, 68.12; H, 4.75; N, 11.97. FT-IR (86%); Rf: 0.75 (n-hexane/ethyl acetate, 5 : 1); m.p. 177–178 1C;
(KBr, cmꢀ1) nmax: 3055 (w), 1361 (s), 1587 (s), 3010 (s), 1596 FT-IR (KBr, cmꢀ1) nmax: 3066 (w), 1352 (s), 1587 (s), 3012 (s),
1
(s), 1492 (s), 1249–1211 (m). 1H NMR (500 MHz, CDCl3): d 15.23 1598 (s), 1490 (m), 1247–1215 (m). H NMR (500 MHz, CDCl3):
(s, 1H), 8.12 (d, J = 8.73 Hz, 2H), 8.04 (d, J = 2.39 Hz, 1H), 7.67 d 15.25 (s, 1H), 8.07 (d, J = 8.78 Hz, 2H), 8.02 (d, J = 2.26 Hz, 1H),
(t, J = 7.57 Hz, 2H), 7.43 (d, J = 7.73 Hz, 2H), 7.40 (m, 3H), 7.19 7.55 (d, J = 8.65 Hz, 2H), 7.42 (t, J = 7.92 Hz, 2H), 7.34 (d, J = 8.68 Hz,
(t, J = 7.42 Hz, 1H), 7.13 (d, J = 8.40 Hz, 2H), 7.03 (d, J = 8.73 Hz, 2H), 7.20 (t, J = 7.39 Hz, 1H), 7.10 (d, J = 8.00 Hz, 2H), 7.01
2H), 6.98 (dd, J = 8.54 and 2.45 Hz, 1H), 6.87 (d, J = 8.61 Hz, 1H), (d, J = 8.76 Hz, 2H), 6.98 (d, J = 2.23 Hz, 1H), 6.86 (d, J = 8.65 Hz,
3.90 (s, 3H). 13C NMR (126 MHz, CDCl3): d 159.75, 156.66, 1H), 3.89 (s, 3H). 13C NMR (126 MHz, CDCl3): d 159.80, 156.56,
151.36, 143.63, 142.49, 137.44, 130.64, 130.30, 130.09, 129.84, 149.78, 143.71, 142.60, 137.23, 136.29, 130.36, 130.16, 129.63,
129.21, 127.53, 123.89, 123.53, 121.73, 119.83, 118.18, 114.89, 129.45, 127.48, 124.02, 123.88, 122.76, 119.83, 118.13, 114.95,
113.88, 55.39. ESI-MS m/z: 457.1 ((M + H)+, 18%); 456.1 ((M)+, 113.90, 55.38. ESI-MS m/z: 536.1 ((M + 2H)ꢀ, 28%); 535.1 ((M + H)ꢀ,
13%); 455.1 ((M ꢀ H)+, 50%). ESI-MS/MS m/z: 318.2 (100%); 23%); 534.0 ((M)ꢀ, 100%). ESI-MS/MS m/z: 294.8 (19%); 255.1
304.3 (87%); 244.3 (6%).
(18%); 202.8 (100%).
5-(4-Chloro-2-phenoxyphenyl)-1,3-bis(4-methoxyphenyl)formazan
5-(4-Chloro-2-phenoxyphenyl)-3-(4-methoxyphenyl)-1-(4-fluoro-
(5b). This compound was obtained from 3b (1.50 g, 5.90 mmol) phenyl)formazan (5e). This compound was obtained from 3e
and diazonium salt 4 (1.29 g, 5.90 mmol) as a red solid. Anal. (1.20 g, 3.90 mmol) and diazonium salt 4 (0.86 g, 4.90 mmol) as
calcd for C27H23ClN4O3 (%): C, 66.60; H, 4.76; N, 11.51; found: C, a red solid. Anal. calcd for C26H20ClFN4O2 (%): C, 65.75; H,
66.85; H, 4.89; N, 11.24. Yield: 1.68 g (59%); Rf: 0.48 (n-hexane/ 4.24; N, 11.80; found: C, 65.45; H, 4.33; N, 11.83. Yield: 2.18 g
ethyl acetate, 5 : 1); m.p. 164–166 1C; FT-IR (KBr, cmꢀ1) nmax: 3068 (70%); Rf: 0.71 (n-hexane/ethyl acetate, 5 : 1); m.p. 158–160 1C;
(w), 1352 (s), 1583 (s), 3004 (s), 1596 (s), 1461 (s), 1253–1215 (m). FT-IR (KBr, cmꢀ1) nmax: 3068 (w), 1359 (s), 1508 (s), 3005 (s),
1
1H NMR (500 MHz, CDCl3): d 14.87 (s, 1H), 8.10 (d, J = 8.56 Hz, 1589 (s), 1494 (m), 1245–1211 (m). H NMR (500 MHz, CDCl3):
2H), 8.00 (d, J = 2.03 Hz, 1H), 7.69 (d, J = 8.64 Hz, 2H), 7.42 d 15.09 (s, 1H), 8.08 (d, J = 8.83 Hz, 2H), 8.01 (d, J = 2.40 Hz,
(t, J = 7.65 Hz, 2H), 7.18 (t, J = 7.33 Hz, 1H), 7.12 (d, J = 8.35 Hz, 1H), 7.66 (dd, J = 8.84, 5.25 Hz, 2H), 7.43 (t, J = 7.96 Hz, 2H),
2H), 7.02 (d, J = 8.55 Hz, 2H), 6.91 (d, J = 8.45 Hz, 3H), 6.83 7.19 (t, J = 7.40 Hz, 1H), 7.10 (d, J = 7.64 Hz, 2H), 7.07
(d, J = 8.56 Hz, 1H), 3.88 (s, 6H). 13C NMR (126 MHz, CDCl3): (d, J = 8.44 Hz, 2H), 7.01 (d, J = 8.84 Hz, 2H), 6.95 (dd, J = 8.60
d 162.54, 159.70, 156.78, 146.65, 142.42, 142.37, 137.02, 130.35, and 2.42 Hz, 1H), 6.84 (d, J = 8.59 Hz, 1H), 3.92 (s, 3H). 13C NMR
130.26, 130.05, 129.94, 129.48, 128.81, 127.67, 126.51, 124.31, (126 MHz, CDCl3): d 165.37, 163.36, 159.78, 156.63, 148.49,
123.75, 122.00, 119.72, 118.07, 114.53, 114.43, 114.09, 113.98, 148.47, 142.92, 142.41, 136.88, 130.38, 130.12, 129.67, 127.52,
55.65, 55.38 (2C). ESI-MS m/z: 487.1 ((M + H)+, 34%); 486.1 ((M)+, 124.04, 123.97, 123.93, 123.01, 119.77, 118.07, 116.34, 116.15,
28%); 485.1 ((M ꢀ H)+, 100%). ESI-MS/MS m/z: 350.0 (4%); 230.9 114.80, 113.87, 55.37. ESI-MS m/z: 475.0 ((M + H)ꢀ, 34%); 474.0
(5%); 168.0 (32%).
((M)ꢀ, 28%); 473.1 ((M ꢀ H)ꢀ, 100%). ESI-MS/MS m/z: 268.9
(47%); 234.8 (28%); 202.8 (100%).
5-(4-Chloro-2-phenoxyphenyl)-3-(4-methoxyphenyl)-1-(4-chloro-
phenyl)formazan (5c). This compound was obtained from 3c
5-(4-Chloro-2-phenoxyphenyl)-3-(4-methoxyphenyl)-1-(4-nitro-
(1.20 g, 4.60 mmol) and diazonium salt 4 (1.01 g, 4.60 mmol) as phenyl)formazan (5f). This compound was obtained from 3f
a claret solid. Anal. calcd for C26H20Cl2N4O2 (%): C, 63.55; H, (1.50 g, 5.50 mmol) and diazonium salt 4 (1.22 g, 5.50 mmol)
4.10; N, 11.40; found: C, 63.36; H, 4.25; N, 11.18. Yield: 1.64 g as a darkish solid. Anal. calcd for C26H20ClN5O4 (%): C, 62.22;
(73%); Rf: 0.80 (n-hexane/ethyl acetate, 5 : 1); m.p. 164–166 1C; H, 4.02; N, 13.95; found: C, 61.95; H, 4.09; N, 13.92. Yield:
FT-IR (KBr, cmꢀ1) nmax: 3074 (w), 1353 (s), 1587 (s), 3010 (s), 1.60 g (58%); Rf: 0.86 (n-hexane/ethyl acetate, 5 : 1); m.p. 211–
1598 (s), 1490 (m), 1249–1215 (m). 1H NMR (500 MHz, CDCl3): d 213 1C; FT-IR (KBr, cmꢀ1) nmax: 3076 (w), 1371 (s), 1502 (s),
15.20 (s, 1H), 8.07 (d, J = 8.81 Hz, 2H), 8.03 (d, J = 2.31 Hz, 1H), 3004 (s), 1591 (s), 1471 (m), 1249–1213 (m). 1H NMR
This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2015
New J. Chem.